Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4965 SEK | -2.07% | -0.70% | +8.76% |
05-22 | Active Biotech Secures Exclusive Licensing Rights to Multiple Myeloma Drug | MT |
05-08 | Active Biotech AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
- Stock Market
- Equities
- ACTI Stock
- Charts Active Biotech AB
- Static Chart